Apeloa Pharmaceutical News

Prologis Pharmaceutical (000739): Steady growth in performance has had an impact on short-term exchange

caitong securitiesOct 22 07:56

Prologis Pharmaceutical (000739): Performance is in line with expectations and is steadily advancing preparations overseas and synthetic biology

china international capital corporationOct 20 00:00

Pro-Pharmaceuticals (000739): Exchange Fluctuations Affect Current Profits New 2030 Strategy to Lead Businesses to Continue to Develop New Growth Forces

china merchantsOct 20 00:00

Prologis Pharmaceuticals (000739): Strong 24H1 performance, rapid growth in the formulation business

Aug 23 00:00

Prologis Pharmaceutical (000739): Record high performance, enhanced competitiveness of raw materials & CDMO & formulations

Aug 22 15:36

Pro-Pharmaceuticals (000739): Improving operational efficiency and R&D helping improve profitability

Aug 21 18:51

Prologis Pharmaceutical (000739): Record high business performance, impressive growth rate of APIs and formulations

Aug 20 18:46

Prologis Pharmaceutical (000739): Formulation growth is strong, APIs strengthen competitiveness

Aug 19 18:11

Prologis Pharmaceutical (000739) Company Brief Evaluation Report: 2024H1 Performance Exceeds Expectations, Rapid Growth in Formulation Business

Aug 19 00:00

Prologis Pharmaceutical (000739): Exceeding expectations under high base numbers is optimistic about H2 performance

Aug 17 00:00

Propharmaceuticals (000739): Strong growth in the API sector, which exceeded expectations in the first half of 2024

Aug 16 14:31

Prologis Pharmaceutical (000739): Achieving double growth in revenue and profit under a high base

Apr 26 18:26

Guoxin Securities released a research report on April 26 stating that it gave Proplo Pharmaceutical (000739.SZ) a purchase rating. The main reasons for the rating include: 1) Under the high base of the same period in 2023, the company achieved double grow

Zhitong FinanceApr 26 17:58

Zhongtai Securities released a research report on April 23 stating that it gave Proplo Pharmaceutical (000739.SZ) a purchase rating. The main reasons for the rating include: 1) in line with expectations, steady growth in performance under industry pressur

Zhitong FinanceApr 25 07:42

Prologis Pharmaceutical (000739): Performance is in line with expectations, growth is resilient

Apr 23 00:00

Pro-Pharmaceuticals (000739): Profit improved month-on-month to achieve growth under a high base

Apr 19 00:00

Prologis Pharmaceutical (000739): Deepening the layout and rapid growth in performance on a booming circuit

Apr 9 00:00

Prologis Pharmaceutical (000739): Continuously improving R&D capabilities to further improve operational efficiency

Mar 22 18:36

Prodrug Pharmaceutical (000739): The risk of price reduction of APIs has been implemented, and the inflection point of performance growth has reached

Mar 14 16:21

Pro-Pharmaceuticals (000739): Increased profitability, high CDMO growth

Mar 12 07:16